BT-1769

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBT-1769
Drug Alias NameBT-1769
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionApoptosis stimulantsMitosis inhibitorsTubulin polymerisation inhibitors +[4] 
TargetsTubulin
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBicycle Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Therapeutics
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A